BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 11727528)

  • 1. Alphavirus vectors: development and potential therapeutic applications.
    Schlesinger S
    Expert Opin Biol Ther; 2001 Mar; 1(2):177-91. PubMed ID: 11727528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alphavirus vectors for cancer gene therapy (review).
    Yamanaka R
    Int J Oncol; 2004 Apr; 24(4):919-23. PubMed ID: 15010830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An alphavirus replicon particle chimera derived from venezuelan equine encephalitis and sindbis viruses is a potent gene-based vaccine delivery vector.
    Perri S; Greer CE; Thudium K; Doe B; Legg H; Liu H; Romero RE; Tang Z; Bin Q; Dubensky TW; Vajdy M; Otten GR; Polo JM
    J Virol; 2003 Oct; 77(19):10394-403. PubMed ID: 12970424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Channeling the Natural Properties of Sindbis Alphavirus for Targeted Tumor Therapy.
    Pampeno C; Hurtado A; Opp S; Meruelo D
    Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alphavirus vectors for gene therapy applications.
    Lundstrom K
    Curr Gene Ther; 2001 May; 1(1):19-29. PubMed ID: 12109136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Old World and New World alphaviruses use different virus-specific proteins for induction of transcriptional shutoff.
    Garmashova N; Gorchakov R; Volkova E; Paessler S; Frolova E; Frolov I
    J Virol; 2007 Mar; 81(5):2472-84. PubMed ID: 17108023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alphavirus vectors as tools in cancer gene therapy.
    Lundstrom K
    Technol Cancer Res Treat; 2002 Feb; 1(1):83-8. PubMed ID: 12614181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential of alphavirus vectors in the treatment of advanced solid tumors.
    Kelly BJ; Fleeton MN; Atkins GJ
    Recent Pat Anticancer Drug Discov; 2007 Jun; 2(2):159-66. PubMed ID: 18221060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo.
    Pushko P; Parker M; Ludwig GV; Davis NL; Johnston RE; Smith JF
    Virology; 1997 Dec; 239(2):389-401. PubMed ID: 9434729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alphavirus DNA and particle replicons for vaccines and gene therapy.
    Polo JM; Gardner JP; Ji Y; Belli BA; Driver DA; Sherrill S; Perri S; Liu MA; Dubensky TW
    Dev Biol (Basel); 2000; 104():181-5. PubMed ID: 11713818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-viral amplification systems for gene transfer: vectors based on alphaviruses.
    Smerdou C; Liljeström P
    Curr Opin Mol Ther; 1999 Apr; 1(2):244-51. PubMed ID: 11715947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alphavirus-Based Antigen Preparation.
    Lundstrom K
    Methods Mol Biol; 2021; 2183():63-81. PubMed ID: 32959241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stable alphavirus packaging cell lines for Sindbis virus and Semliki Forest virus-derived vectors.
    Polo JM; Belli BA; Driver DA; Frolov I; Sherrill S; Hariharan MJ; Townsend K; Perri S; Mento SJ; Jolly DJ; Chang SM; Schlesinger S; Dubensky TW
    Proc Natl Acad Sci U S A; 1999 Apr; 96(8):4598-603. PubMed ID: 10200308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alphaviruses and their derived vectors as anti-tumor agents.
    Atkins GJ; Smyth JW; Fleeton MN; Galbraith SE; Sheahan BJ
    Curr Cancer Drug Targets; 2004 Nov; 4(7):597-607. PubMed ID: 15578917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complete sequence of the genomic RNA of O'nyong-nyong virus and its use in the construction of alphavirus phylogenetic trees.
    Levinson RS; Strauss JH; Strauss EG
    Virology; 1990 Mar; 175(1):110-23. PubMed ID: 2155505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alphaviral vectors for gene transfer into neurons.
    Ehrengruber MU
    Mol Neurobiol; 2002; 26(2-3):183-201. PubMed ID: 12428755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alphaviruses in gene therapy.
    Lundstrom K
    Viruses; 2009 Jun; 1(1):13-25. PubMed ID: 21994535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stable, high-level expression of reporter proteins from improved alphavirus expression vectors to track replication and dissemination during encephalitic and arthritogenic disease.
    Sun C; Gardner CL; Watson AM; Ryman KD; Klimstra WB
    J Virol; 2014 Feb; 88(4):2035-46. PubMed ID: 24307590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A vaccinia virus recombinant transcribing an alphavirus replicon and expressing alphavirus structural proteins leads to packaging of alphavirus infectious single cycle particles.
    Sánchez-Puig JM; Lorenzo MM; Blasco R
    PLoS One; 2013; 8(10):e75574. PubMed ID: 24130722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic and prophylactic applications of alphavirus vectors.
    Atkins GJ; Fleeton MN; Sheahan BJ
    Expert Rev Mol Med; 2008 Nov; 10():e33. PubMed ID: 19000329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.